TCL Archive Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years May 9, 2014
TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007
TCL Archive AACI Backs Year 200 Goals, Secures Pledge From NCI that New Centers Won’t Be Added At Expense of Old July 20, 1984
